These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach. Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404 [TBL] [Abstract][Full Text] [Related]
28. Spatially and time-resolved SAXS for monitoring dynamic structural transitions during in situ generation of non-lamellar liquid crystalline phases in biologically relevant media. Mertz N; Yaghmur A; Østergaard J; Amenitsch H; Larsen SW J Colloid Interface Sci; 2021 Nov; 602():415-425. PubMed ID: 34144300 [TBL] [Abstract][Full Text] [Related]
29. Cubosomes as an emerging platform for drug delivery: a review of the state of the art. Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858 [TBL] [Abstract][Full Text] [Related]
31. Accelerated formation of cubic phases in phosphatidylethanolamine dispersions. Tenchov B; Koynova R; Rapp G Biophys J; 1998 Aug; 75(2):853-66. PubMed ID: 9675186 [TBL] [Abstract][Full Text] [Related]
32. Novel Amphiphilic Block Copolymers for the Formation of Stimuli-Responsive Non-Lamellar Lipid Nanoparticles. Zhai J; Fan B; Thang SH; Drummond CJ Molecules; 2021 Jun; 26(12):. PubMed ID: 34203820 [TBL] [Abstract][Full Text] [Related]
33. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263 [TBL] [Abstract][Full Text] [Related]
34. Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin. Nielsen LH; Rades T; Boyd B; Boisen A Eur J Pharm Biopharm; 2017 Sep; 118():13-20. PubMed ID: 27993733 [TBL] [Abstract][Full Text] [Related]
36. A systematic study of the effect of lipid architecture on cytotoxicity and cellular uptake of cationic cubosomes. Pushpa Ragini S; Dyett BP; Sarkar S; Zhai J; White JF; Banerjee R; Drummond CJ; Conn CE J Colloid Interface Sci; 2024 Jun; 663():82-93. PubMed ID: 38394820 [TBL] [Abstract][Full Text] [Related]
37. Antibacterial and anti-biofilm activities of antibiotic-free phosphatidylglycerol/docosahexaenoic acid lamellar and non-lamellar liquid crystalline nanoparticles. Jan H; Ghayas S; Higazy D; Ahmad NM; Yaghmur A; Ciofu O J Colloid Interface Sci; 2024 Sep; 669():537-551. PubMed ID: 38729002 [TBL] [Abstract][Full Text] [Related]
38. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells. Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797 [TBL] [Abstract][Full Text] [Related]
39. In situ monitoring of the formation of lipidic non-lamellar liquid crystalline depot formulations in synovial fluid. Yaghmur A; Rappolt M; Jonassen ALU; Schmitt M; Larsen SW J Colloid Interface Sci; 2021 Jan; 582(Pt B):773-781. PubMed ID: 32916575 [TBL] [Abstract][Full Text] [Related]